Revenue
$7.9m
-4.7% ↓ vs $8.3m
Losses narrowed materially, but a $5.6m operating cash burn left only $0.9m of cash against $12.4m of borrowings.
Revenue context before the current result.
EBITDA margin across covered periods.
Operating cash flow across covered periods.
Operating working-capital absorption or release by reporting period.
Key metrics
FY23 vs FY22
Revenue
$7.9m
-4.7% ↓ vs $8.3m
EBITDA
−$5.2m
+8.9% ↑ vs −$5.7m
Net profit after tax
−$13m
+33.3% ↑ vs −$19.5m
Net cash inflow from operating activities
−$5.6m
+52.0% ↑ vs −$11.6m
Operating profit
−$7.4m
+15.8% ↑ vs −$8.8m
Profit before tax
−$13m
+41.2% ↑ vs −$22.1m
Cash and cash equivalents
$0.91m
-83.0% ↓ vs $5.4m
Total assets
$27m
-31.7% ↓ vs $39.5m
What changed
Cash and equivalents fell 83.0% to NZ$0.9m (from NZ$5.4m), while gross borrowings edged up to NZ$12.4m and total equity halved to NZ$11.9m (-50.5%). Operating cash outflow improved to NZ$5.6m from NZ$11.6m, yet still consumed almost all of the prior cash balance.
On the P&L, revenue declined 4.7% to NZ$7.9m, EBITDA loss narrowed 8.9% to NZ$5.2m, PBT loss narrowed 41.4% to NZ$13.0m, and NPAT loss narrowed 33.6% to NZ$13.0m. Honey grew to NZ$5.8m and now contributes 63.2% of revenue (up from 57.0%); Me Today branded sales of NZ$2.8m shrank its share to 30.2%.
What matters
Expectations
The half-year shape shows H1 carried 59.7% of full-year EBITDA loss and 44.8% of full-year NPAT loss, implying an H2 EBITDA loss of NZ$2.1m (improving) but an H2 NPAT loss of NZ$7.2m (worsening). The widening H2 NPAT gap, in the absence of further explanation, points to below-EBITDA charges in the second half that the release does not itemise in the supplied excerpts. This matters because it leaves the trajectory into FY24 ambiguous: EBITDA momentum looks better, but reported NPAT got worse in the second half.
Quality of result
Operating cash conversion of 108.0% of EBITDA is within the company's historical range (3-period mean 98.9%), so the cash burn tracks the EBITDA loss rather than masking it; however, that simply confirms the business consumes cash in line with operating losses, not that it is approaching cash generation. Free cash flow before leases of -NZ$5.6m is within the company's historical baseline (mean -NZ$5.4m), which means the result is not a one-off improvement in capital intensity — capex was suppressed to NZ$0.04m (0.4% of revenue, down from 4.0%).
Working capital provided a modest tailwind: inventories fell NZ$2.0m (-12.1%) as honey stocks were worked down, partially offset by trade debtors rising 81.8% to NZ$1.7m, lifting debtor days to 76.9 (from 40.3). The receivable build is a watch-point because it converts reported revenue into balance-sheet exposure rather than cash, and it sits alongside inventory days of 683.5 that remain very high in absolute terms.
Unresolved
This briefing cannot assess management's specific funding intentions, covenant headroom, or the post-balance-date liquidity position because no capital-raising plan, banking-facility detail, or going-concern commentary was supplied with the extraction.
Chat
Ask follow-up questions about Me Today's FY23 result.
Informational only. No buy, sell, hold, price-target, or personal financial advice.
Informational only. No buy, sell, hold, price-target, or personal financial advice.
Open to load segment breakdown.
Open to load analytical metrics.
Open to load key metrics.
30 June 2023 Financial Statements - Market Announcement
FY23 / results releaseMe Today - Financial Statements 12 months ended 30 June 2023
FY23 / financial reportRule 3.5 schedule at 29 August 2023
FY23 / results announcementMe Today June 2022 Annual Report
FY22 / financial report31 December 2022 Financial Statements - Market Announcement
HY23 / results releaseMe Today HY23 Interim Financial Statements 6 months ended 31 December 2022
HY23 / financial reportRelated insights
Cross-company views selected from the metrics in this briefing.
Cash conversion quality
This result converted 108.0% of EBITDA to operating cash flow, -96.8pp versus the prior comparable period.
Earnings quality and statutory distortions
PBT and NPAT growth diverged by 7.8pp, with a distortion flag in the result.
ROE and capital efficiency
ROE was -108.7%, -27.6pp versus the prior comparable period.
Leverage and balance-sheet risk
Net debt / EBITDA is -2.20x, -1.00x versus the prior comparable period.
Get the next Me Today briefing and related NZX reporting-season updates by email.